2016 American Transplant Congress Archives - Page 101 of 180

Long-Term Outcomes in Epstein-Barr Virus (EBV)-Positive Patients Receiving Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.

S. Florman,¹ J. Medina Pestana,² M. del C Rial,³ L. Rostaing,⁴ D. Kuypers,⁵ A. Matas,⁶ T. Wekerle,⁷ J. Grinyó,⁸ U. Meier-Kriesche,⁹ M. Polinsky,⁹ H. Zhao,⁹ A. Durrbach.¹⁰
Long-Term Outcomes in Pediatric Live-Donor Liver Transplantation.

N. Celik,¹ A. Ganoza,² F. Vyas,¹ J. Squires,³ V. Venkat,³ G. Bond,¹ K. Soltys,¹ R. Sindhi,¹ R. Squires,³ A. Humar,² G. Mazariegos.¹
Long-Term Outcomes of ATG versus IL-2 Receptor Antagonist in Low Risk Kidney Transplant Recipients: Donor Factors.

F. Al Ammary, S. Bae, A. Massie, N. Desai, N. Dagher, E. Kraus, A. Wiseman, D. Segev.
Long-Term Renal Allograft Outcome After Parathyroidectomy.

M. Patecki, I. Scheffner, H. Haller, W. Gwinner.
Long-Term vs Short-Term Valganciclovir Prophylaxis Use for Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Living Related Liver Transplantation.

T. Ueno,¹ H. Yamanaka,¹ Y. Takama,¹ N. Tanaka,¹ Y. Tazuke,¹ K. Bessho,² H. Okuyama.¹
Longitudinal Psychological Outcomes of Living Liver Donors.

Z. Butt,¹ M. Dew,² Q. Liu,³ M. Simpson,⁴ A. Smith,^3,5 J. Zee,³ B. Gillespie,⁵ S. Abbey,⁶ D. Ladner,¹ R. Weinreib,⁷ R. Fisher,⁸ S. Hafliger,⁹ N. Terrault,¹⁰ J. Burton,¹¹ A. DiMartini.²
Low Pretransplant BMI/Weight and Changes in Posttransplant T Cell Exhaustion Levels Are Associated with Viremia/Viral Infection in Pediatric Kidney Transplantation in the First Post-Transplant Year – A Report from the IMPACT Study Consortium.

R. Ettenger,¹ H. Chin,² P. Grimm,³ K. Kesler,² E. Reed,⁴ M. Sarwal,⁵ B. Warshaw,⁶ E. Tsai,¹ A. Kirk.⁷
Low Risk of Cytomegalovirus (CMV) Transmission in Clinical Islet Transplantation.

D. Kabbani,¹ K. Cheung,² P. Senior,² C. Cervera,¹ K. Doucette,¹ J. Preiksaitis.¹
Low-Pressure Pneumoperitoneum in Living Kidney Donors: An Age-Dependent Analysis of Recipient Outcomes.

S. Kulkarni,¹ S. Douglas,² E. Cohen,¹ S. Swift,¹ I. Hall.²
Lower Rates of Living Donor Kidney Transplantation(LD) Among African Americans: What Prevents Higher Rates of Donation?

A. Li, N. Foreman, M. Reissmann, C. Zuttermeister, A. Gilbert, M. Grafals, B. Javaid, S. Ghasemian, P. Abrams, M. Cooper, J. Verbesey.